Lithuanian Sports University
Kaunas, LT-44221, Lithuania
NCT Number: NCT07504718
The goal of this observational study is to examine how different physiological markers change over a two-day period after long-duration whole-body cold-water immersion in healthy young men and women. Specifically, the study aims to address the following questions:
* How do kynurenine pathway metabolites change after cold exposure? * How do stress markers change after cold exposure? * How do cytokine levels change after cold exposure? * How do white blood cells count and distribution change after cold exposure?
Looking for future studies?
Notify Me18 year–36 year
All sexes
Interventional
Not applicable
Kaunas, LT-44221, Lithuania
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention consisted of intermittent whole-body immersion in 14 °C water. After 20 min of immersion, the subject exited from the bath and rested for 10 min by sitting in the room environment, and then the same procedure was repeated. The cold stress continued until 170 min in total (120 min maximum total immersion time).
Time frame: 2 days
An ultra-performance liquid chromatography-tandem mass spectrometry system (UPLC-MS/MS) was used to measure venous plasma levels of tryptophan, kynurenine, kynurenic acid, 3-hydroxy-kynurenine, quinolinic acid, nicotinamide and picolinic acid (in μm). The UPLC-MS/MS system uses a Xevo TQ-XS triple quadrupole mass spectrometer (Waters) with a Z-spray electrospray interface, and the system operates in electrospray positive multiple reaction monitoring mode.
Time frame: 1 day
Rectal temperature (in °C) was measured using a thermocouple (Rectal Probe, Ellab, Denmark) inserted to a depth of 12 cm past the anal sphincter, skin temperature (in °C) was measured with thermistors (Skin/Surface Probe, DM852, Ellab).
Time frame: 1 day
A cold strain index (CSI) was used to indicate cold strain. CSI = 6.67 x (Tre t - Tre 0) x (35 - Tre 0)^-1 + 3.33 x (Tsk t - Tsk 0) x (20 - Tsk 0)^-1, where rectal temperature (Tre) 0 and skin temperature (Tsk) 0 are initial measurements and Tre t and Tsk t are simultaneous measurements taken at the end of the cold exposure.
Time frame: 2 days
The saliva samples was collected to measure free cortisol level (in µg/dl) using an ELISA kit and a Spark multimode microplate reader (Tecan, Austria).
Time frame: 2 days
The venous tumor necrosis factor alpha and interleukin-6 (in pg/ml) were measured using an ELISA kits and a Gemini Analyzer (Stratec Biomedical GmbH, Birkenfeld, Germany)
Time frame: 2 days
The venous total cortisol consentration (in nmol/l) was measured using an ELISA kit and an automated enzyme immunoassay analyzer (AIA-2000; Tosoh Corp., Tokyo, Japan).
Time frame: 2 days
The venous adrenaline and noradrenaline concentrations (in ng/ ml) were measured using an Elisa kit and a Spark multimode microplate reader (Tecan, Austria).
Time frame: 2 days
Complete blood count with 5 different white blood count components (absolute neutrophils, lymphocytes, monocytes, eosinophils, basophils) analysis (in 10^9/L) was performed using an automated hematology analyzer (XE-5000, Sysmex Corp, Kobe, Japan).
Time frame: 2 days
The glucose concentration (in mmol/l) was measured using a Cardiocheck PA analyzer (Polymer Technology Systems Inc, Indianapolis, IN, USA).
Lithuanian Sports University
Other
The Effect of Cold Water Immersion on Physiological Markers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737015
Healthy Adult Participants
Aarhus, Denmark
View Trial DetailsNCT07694401
Healthy Adult Participants
Suchdol, Prague, Czechia
View Trial DetailsNCT07682857
Glucose Metabolism Disorders, Healthy Adult Participants
Torino, Italy
View Trial DetailsNCT07571824
Healthy Adult Participants
Las Vegas, Nevada, United States
View Trial Details